Pearce Catherine 4
4 · CinCor Pharma, Inc. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Pearce Catherine
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-11+13,235→ 144,146 total - Tax Payment
Common Stock
2023-01-11$28.75/sh−3,997$114,914→ 140,149 total - Exercise/Conversion
Restricted Stock Units
2023-01-11−13,235→ 13,236 total→ Common Stock (13,235 underlying)
Holdings
- 1,500(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F2]The securities are held by the Reporting Person's spouse. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her proportionate pecuniary interest therein.
- [F3]The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.